<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02086422</url>
  </required_header>
  <id_info>
    <org_study_id>CD13/10799</org_study_id>
    <nct_id>NCT02086422</nct_id>
  </id_info>
  <brief_title>Iatrogenic Chronotropic Incompetence and Exercise Tolerance in Heart Failure</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Leeds Teaching Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Leeds Teaching Hospitals NHS Trust</source>
  <brief_summary>
    <textblock>
      Patients with CHF benefit from heart rate lowering, and the investigators have previously
      demonstrated that this does not adversely affect exercise tolerance. In a pacemaker
      population we also have shown that preventing heart rate lowering is detrimental in terms of
      symptoms and prognosis.

      The aim of the study is to therefore to establish whether heart rate limitation in patients
      with heart failure has a negative impact on exercise capacity. If the investigators establish
      that this is not the case, physicians will be able to confidently prescribe heart rate
      lowering agents, and programme pacemakers to allow bradycardia without the concern that there
      will be detrimental effects of symptom.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Examining the effects of iatrogenic CI on exercise capacity</measure>
    <time_frame>24 months</time_frame>
    <description>Each subject will undergo a full echocardiographic examination.We will assess LV systolic and diastolic function variables, mitral regurgitation, and pulmonary artery pressure.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>ivabradine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise with ivabradine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Exercise with placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ivabradine</intervention_name>
    <arm_group_label>ivabradine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <arm_group_label>ivabradine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to walk on a treadmill Able to provide consent Heart failure (or not) depending
             upon the arm. Patients with atrial fibrillation to have had an AV node ablation (or
             very slow response to AF)

        Exclusion Criteria:

          -  Cognitive impairment, known reaction to ivabradine, musculoskeletal issues limiting
             walking on a treadmill.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Klaus Witte, FRCP, MD</last_name>
    <phone>01133926642</phone>
    <email>k.k.witte@leeds.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Leeds Teaching Hospitals NHS Trust</name>
      <address>
        <city>Leeds</city>
        <zip>LS2 9JT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Witte, FRCP, MD</last_name>
      <phone>01133926642</phone>
      <email>k.k.witte@leeds.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2013</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>February 25, 2016</last_update_submitted>
  <last_update_submitted_qc>February 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

